# Role of Hemostatic Powder (Endo-clotTM) in Prevention of Bleeding Within High Risk Patients After ESD

> **NCT02625792** · PHASE3 · COMPLETED · sponsor: **Yonsei University** · enrollment: 45 (actual)

## Conditions studied

- Iatrogenic Ulcer After ESD

## Interventions

- **DRUG:** Endo-Clot(TM)

## Key facts

- **NCT ID:** NCT02625792
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2017-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02625792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02625792, "Role of Hemostatic Powder (Endo-clotTM) in Prevention of Bleeding Within High Risk Patients After ESD". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02625792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*